Literature DB >> 10960532

Public perception of the risk of blood transfusion.

M L Finucane1, P Slovic, C K Mertz.   

Abstract

BACKGROUND: Health policymakers are concerned about the proportion of people who say they are unwilling to receive a blood transfusion. This article examines how social, cultural, and political factors affect the perceived risk of transfusions. STUDY DESIGN AND METHODS: Data were collected as part of a large national telephone survey of 1204 people conducted in the United States in 1997 and 1998. The survey elicited images associated with blood transfusions and contained questions about the perceived risk of the blood supply, sensitivity to stigma, world views, trust, and demographics.
RESULTS: The results showed that a substantial proportion of people do not consider the US blood supply to be safe and say they would not accept blood if hospitalized. The images evoked most frequently by the stimulus phrase "blood transfusions" were related to AIDS or HIV. The people who tend to perceive the greatest personal and public risk from blood transfusions are female, nonwhite, and less educated, and they have not previously received a transfusion. Sensitivity to stigma, mistrust, one's perceived inability to control hazardous activities and technologies, and fatalistic and egalitarian world views tend to be associated with heightened concern about the risk of blood transfusions.
CONCLUSION: Risk perceptions need to be monitored to anticipate and deal with problems of public acceptance. Risk management strategies should be tailored to the specific characteristics of individuals that are important determinants of the perceived risk of transfusions.

Entities:  

Mesh:

Year:  2000        PMID: 10960532     DOI: 10.1046/j.1537-2995.2000.40081017.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  17 in total

1.  Reversal of hemoglobin-induced vasoconstriction with sustained release of nitric oxide.

Authors:  Pedro Cabrales; George Han; Parimala Nacharaju; Adam J Friedman; Joel M Friedman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-05       Impact factor: 4.733

2.  Safety in transfusion medicine.

Authors:  Giuseppe Aprili
Journal:  Blood Transfus       Date:  2008-07       Impact factor: 3.443

Review 3.  Examining and mitigating acellular hemoglobin vasoactivity.

Authors:  Pedro Cabrales
Journal:  Antioxid Redox Signal       Date:  2012-10-11       Impact factor: 8.401

4.  Surrogate and patient discrepancy regarding consent for critical care research.

Authors:  Julia T Newman; Alexandra Smart; Tyler R Reese; Andre Williams; Marc Moss
Journal:  Crit Care Med       Date:  2012-09       Impact factor: 7.598

5.  Synthesis, biophysical properties and pharmacokinetics of ultrahigh molecular weight tense and relaxed state polymerized bovine hemoglobins.

Authors:  Paul W Buehler; Yipin Zhou; Pedro Cabrales; Yiping Jia; Guoyong Sun; David R Harris; Amy G Tsai; Marcos Intaglietta; Andre F Palmer
Journal:  Biomaterials       Date:  2010-02-10       Impact factor: 12.479

6.  The tumor promoting roles of erythropoietin/erythropoietin receptor signaling pathway in gastric cancer.

Authors:  Weiling Hu; Yu Zhang; Zhinong Jiang; Lan Wang; Jun Li; Shujie Chen; Ning Dai; Jianmin Si
Journal:  Tumour Biol       Date:  2016-04-16

Review 7.  Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids.

Authors:  Pedro Cabrales; Marcos Intaglietta
Journal:  ASAIO J       Date:  2013 Jul-Aug       Impact factor: 2.872

Review 8.  Clinical and economic impact of epoetins in cancer care.

Authors:  Monia Marchetti; Giovanni Barosi
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

9.  Recombinant erythropoietin for chemotherapy-related anaemia: economic value and health-related quality-of-life assessment using direct utility elicitation and discrete choice experiment methods.

Authors:  Diego F Ossa; Andrew Briggs; Emma McIntosh; Warren Cowell; Tim Littlewood; Mark Sculpher
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

10.  Erythropoietin supports the survival of prostate cancer, but not growth and bone metastasis.

Authors:  Yusuke Shiozawa; Samantha McGee; Michael J Pienta; Natalie McGregor; Younghun Jung; Kenji Yumoto; Jingcheng Wang; Janice E Berry; Kenneth J Pienta; Russell S Taichman
Journal:  J Cell Biochem       Date:  2013-11       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.